Monopar Therapeutics Shares Resume Trade Then Again Halted On Circuit Breaker To The Upside, Stock Now Up 507.8%
Portfolio Pulse from Benzinga Newsdesk
Monopar Therapeutics shares experienced significant volatility, with trading resuming and then being halted again due to a circuit breaker as the stock surged by 507.8%.
October 24, 2024 | 4:20 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Monopar Therapeutics' stock experienced extreme volatility, with a 507.8% increase leading to trading halts due to circuit breakers.
The significant price increase of 507.8% in Monopar Therapeutics' stock indicates strong positive sentiment or news, leading to trading halts due to circuit breakers. This suggests a likely short-term upward trend, but also indicates potential volatility.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100